Cargando…
Therapeutic MK2 inhibition blocks pathological vascular smooth muscle cell phenotype switch
Vascular procedures, such as stenting, angioplasty, and bypass grafting, often fail due to intimal hyperplasia (IH), wherein contractile vascular smooth muscle cells (VSMCs) dedifferentiate to synthetic VSMCs, which are highly proliferative, migratory, and fibrotic. Previous studies suggest MAPK-act...
Autores principales: | Tierney, J. William, Evans, Brian C., Cheung-Flynn, Joyce, Wang, Bo, Colazo, Juan M., Polcz, Monica E., Cook, Rebecca S., Brophy, Colleen M., Duvall, Craig L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525639/ https://www.ncbi.nlm.nih.gov/pubmed/34622803 http://dx.doi.org/10.1172/jci.insight.142339 |
Ejemplares similares
-
Subfailure Overstretch Injury Leads to Reversible Functional Impairment and Purinergic P2X7 Receptor Activation in Intact Vascular Tissue
por: Luo, Weifeng, et al.
Publicado: (2016) -
Normal Saline solutions cause endothelial dysfunction through loss of membrane integrity, ATP release, and inflammatory responses mediated by P2X7R/p38 MAPK/MK2 signaling pathways
por: Cheung-Flynn, Joyce, et al.
Publicado: (2019) -
A cell permeant phosphopeptide mimetic of Niban inhibits p38 MAPK and restores endothelial function after injury
por: Yim, Tsz Wing, et al.
Publicado: (2020) -
An anionic, endosome-escaping polymer to potentiate intracellular delivery of cationic peptides, biomacromolecules, and nanoparticles
por: Evans, Brian C., et al.
Publicado: (2019) -
Endosomolytic Nano-Polyplex Platform Technology for Cytosolic Peptide Delivery To Inhibit Pathological Vasoconstriction
por: Evans, Brian C., et al.
Publicado: (2015)